Skip to main content
FinSpry Logo
FinSpry
BMRN logo
BMRN
(NASDAQ)
BioMarin Pharmaceutical Inc.
$66.53-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BioMarin Pharmaceutical (BMRN) Stock Price & Financial Analysis

BioMarin Pharmaceutical Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$65.52 - $66.64
52-Week High$70.98
52-Week Low$49.26
Open$65.79
Volume2.30M
Average Volume (3M)2.15M
Market Cap13.15B
Shares Outstanding197.67M
P/E Ratio (TTM)48.94
Forward P/E94.61
Price to Sales (P/S)4.06
Price to Book (P/B)2.12
EV/EBITDA26.96
Revenue (TTM)3.24B
Net Income (TTM)268.74M
Free Cash Flow (TTM)759.12M
EPS (TTM)$1.37
Profit Margin8.29%
Operating Margin13.55%
Return on Equity (ROE)4.33%
Debt to Equity0.23
50-Day MA$62.58
200-Day MA$57.85
52-Week Change15.16%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About BioMarin Pharmaceutical

What is the current stock price for BMRN?

As of the latest trading session, BMRN stock trades at $66.53. The 52-week range is $49.26–$70.98, with a day range of $65.52–$66.64.

What is the P/E ratio for BMRN?

BioMarin Pharmaceutical's trailing P/E ratio is 48.9, meaning investors pay $48.9 for every $1 of annual earnings. The forward P/E is 94.6, reflecting analyst expectations for future earnings. BioMarin Pharmaceutical operates in the Healthcare sector.

Does BMRN pay dividends?

BioMarin Pharmaceutical does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BMRN?

Based on 3 analysts, the consensus for BMRN is Hold.

What is the market cap of BMRN?

BioMarin Pharmaceutical's market capitalization is $13.15B, classifying it as a large-cap company. BioMarin Pharmaceutical operates in the Healthcare sector within the Biotechnology industry.